Assembly Biosciences Inc ASMB
News
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program With Gilead
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates

